When stratified by age, a higher risk of dizziness was observed in the ≥65 years age group relative to the <65 years age group within the antihistamine cohort (≥65 years, aHR 0.80 [95% CI 0.61–1.05]; <65 years, aHR 0.38 [95% CI 0.16–0.90]), although this difference did not reach statistical significance.
← all excerpts
Real-World Safety of Cyproheptadine-Based Appetite Stimulants: An Electronic Health Record-Based Retrospective Cohort Study in Adult Patients.
1
—
—